Ligand Pharma CEO John Higgins Retires; Todd Davis To Succeed Higgins As CEO

RTTNews | 874 days ago
Ligand Pharma CEO John Higgins Retires; Todd Davis To Succeed Higgins As CEO

(RTTNews) - Ligand Pharmaceuticals Inc. (LGND) announced Monday that John Higgins has retired as Chief Executive Officer, effective as of today. Higgins will resign as a director of the company on December 31, 2022.

The company's board of directors has named Todd Davis as Chief Executive Officer. Davis is currently a member of Ligand's board of directors and is Managing Partner of RoyaltyRx Capital, a special opportunities investment firm he founded in 2018.

Davis has nearly 30 years of experience in biopharmaceutical and life sciences operations and investing.

Prior to founding RoyaltyRx Capital, Davis was a founder and Managing Partner at HealthCare Royalty Partners, a global healthcare investment firm. Previously, he was a partner responsible for biopharmaceutical growth equity investments at Apax Partners.

Davis began his career at Abbott Laboratories, where he held multiple sales and marketing positions of increasing responsibility. Subsequently, he led corporate development and held strategic planning and general management responsibilities at Elan Pharmaceuticals.

read more
Ligand Says Merck Receives FDA Approval For CAPVAXIVE For Adults

Ligand Says Merck Receives FDA Approval For CAPVAXIVE For Adults

Ligand Pharmaceuticals Inc. (LGND) announced Tuesday that its collaborator Merck & Co., Inc. (MRK), known as MSD outside the U.S. and Canada, has received approval from the U.S. Food and Drug Administration (FDA) for CAPVAXIVE, previously known as V116, a 21-valent pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease and pneumococcal pneumonia in the adult population.
RTTNews | 313 days ago
Swiss Market Ends Modestly Higher

Swiss Market Ends Modestly Higher

The Swiss market closed modestly higher on Friday after moving in a tight bandwith investors digesting earnings updates and continuing to track the developments on the tariff front.
RTTNews | 2 days ago
European Stocks Close Higher

European Stocks Close Higher

Despite lingering uncertainty about U.S. government's trade policy, European stocks closed higher on Friday, with German and French markets gaining for a fourth straight session, and the U.K. moving up for the tenth consecutive session, as investors focused on earnings.
RTTNews | 2 days ago
U.S. Consumer Sentiment Deteriorates Modestly Less Than Estimated In April

U.S. Consumer Sentiment Deteriorates Modestly Less Than Estimated In April

A report released by the University of Michigan on Friday showed consumer sentiment in the U.S. deteriorated modestly less than previously estimated in the month of April. The University of Michigan said its consumer sentiment index for April was upwardly revised to 52.2 from a preliminary reading of 50.8. Economists had expected the index to be unrevised.
RTTNews | 2 days ago
Russia Holds Key Interest Rate As Expected

Russia Holds Key Interest Rate As Expected

The Bank of Russia left its interest rate unchanged as widely expected on Friday, despite high inflationary pressures. The board of directors, governed by Elvira Nabiullina, maintained the key interest rate at a record high 21.00 percent. The Russian central bank has raised the key interest rate by 1,350 basis points since July 2023.
RTTNews | 2 days ago